购物车
- 全部删除
- 您的购物车当前为空
KBU2046 是口服有效的,体外细胞运动和侵袭的高选择性抑制剂。它结合伴侣异源复合物,选择性地改变调节运动性的侣伴蛋白的结合,并且缺乏经典 HSP90抑制剂的所有标志。它抑制癌症转移并延长寿命。
为众多的药物研发团队赋能,
让新药发现更简单!
KBU2046 是口服有效的,体外细胞运动和侵袭的高选择性抑制剂。它结合伴侣异源复合物,选择性地改变调节运动性的侣伴蛋白的结合,并且缺乏经典 HSP90抑制剂的所有标志。它抑制癌症转移并延长寿命。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 198 | 现货 | |
5 mg | ¥ 497 | 现货 | |
10 mg | ¥ 696 | 现货 | |
25 mg | ¥ 1,430 | 现货 | |
50 mg | ¥ 2,230 | 现货 | |
100 mg | ¥ 3,210 | 现货 | |
200 mg | ¥ 4,520 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 548 | 现货 |
产品描述 | KBU2046 is an orally administered compound that inhibits cell motility and invasion, effectively suppressing cancer metastasis and extending lifespan. This compound uniquely targets and binds to chaperone heterocomplexes, selectively modifying the interaction of client proteins involved in motility regulation, while avoiding the characteristics typical of classical HSP90 inhibitors. |
分子量 | 242.24 |
分子式 | C15H11FO2 |
CAS No. | 1143863-69-7 |
Smiles | Fc1ccc(cc1)C1COc2ccccc2C1=O |
密度 | 1.31g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 45 mg/mL (185.77 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容